Olema Pharmaceuticals, Inc. OLMA Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Olema Pharmaceuticals, Inc. (OLMA) reported operating lease liabilities (total) of $956K in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s operating lease liabilities (total) changed year-over-year?
- Olema Pharmaceuticals, Inc.'s operating lease liabilities (total) decreased by 16.7% year-over-year, from $1.15M to $956K.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s operating lease liabilities (total)?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s operating lease liabilities (total) has grown at a -22.4% compound annual growth rate (CAGR), from $3.29M to $1.19M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.